Raum:
Saal London 3
Topic:
Wissenschaftliches Programm
Topic 01: Neurokognitive Erkrankungen, organische psychische Störungen, Demenz, F0
Topic 15: Diagnostik und Klassifikation
Topic 14: Neurobiologie und Genetik
English programme
Format:
Symposium
Dauer:
90 Minuten
Besonderheiten:
Q&A-Funktion
Inflammatory pathomechanisms as possible causes not only for psychosis but also for other psychiatric disorders like depression or dementia play an increasing role not only in basic and clinical research but also in the media. Therefore doctors and specialists are increasingly confronted with patients asking for immunological investigations or immune therapy. The present symposium focusses on this issue. The first contribution will show the results of single-cell immune phenotyping in neuropsychiatric disorders. The second talk will present evidence from clinical research that points to an involvement of inflammation in schizophrenia and affective disorders. A third presentation will tackle the problem of rare but possible causes where seemingly primary idiopathic psychiatric disorders camouflage vasculitic disease. In a final contribution the enigma of Hashimoto’s encephalopathy – a concept of unresolved validity – and it’s implications for clinical psychiatry will be discussed.
Rheumatic or idiopathic psychiatric disorders – an update
Dominique Endres, Freiburg im Breisgau (Germany)
Details anzeigen
Autor:in:
Dominique Endres, Freiburg im Breisgau (Germany)
Inflammatory brain diseases represent an important differential diagnosis to idiopathic psychiatric diseases. With the discovery of anti-NMDA-R encephalitis, the interest in autoimmune inflammatory causes has experienced an enormous upswing in the last decade. In this context, however, long-known rheumatic diseases also play an important role. Diseases such as systemic lupus erythematosus (SLE) can be associated with brain involvement. In this presentation, the clinical significance of such secondary, organically caused psychiatric syndromes (e.g., neuropsychiatric SLE) will be discussed.